← Back to Clinical Trials
Recruiting NCT05485675

NCT05485675 Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05485675
Status Recruiting
Phase
Sponsor Arizona State University
Condition Sedentary Behavior
Study Type INTERVENTIONAL
Enrollment 4,800 participants
Start Date 2022-10-07
Primary Completion 2026-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Stand & Move at WorkStand & Move at Work+

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 4,800 participants in total. It began in 2022-10-07 with a primary completion date of 2026-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a 2-arm group-randomized hybrid effectiveness-implementation (HEI type 2) study to test an evidence-based intervention (EBI) known as Stand \& Move at Work(SMW) to reduce sedentary time in the workplace, and to test the role of expert facilitation (SMW+) for improving intervention fidelity.

Eligibility Criteria

Worksite-Level Inclusion Criteria: * More than 80% of employees work full time (30+ hours per week). * At least 45 employees in the worksite with sit-stand workstations working at least three days per week * Occupations require primarily desk-based work (e.g., computer- and telephone-based) * Willing to allow the researchers to distribute online research surveys to all employees in order to allow the program to be evaluated. * Allow 30 randomly selected individuals to wear an activity monitor in several 7-day intervals across two years. * Willing to be randomized to either intervention. * Willing to identify one or more worksite champions to implement the Stand \& Move at Work™ program. Worksite-level exclusion criteria: * Involved in previous interventions to reduce sitting and increase standing and moving at work in the last 24 months. * Involved in the Stand and Move I intervention. * Another worksite within the same organization is participating in the program and contamination across those worksites cannot be avoided. Employee-level inclusion criteria: * 18 years or older * Willing to provide informed consent

Contact & Investigator

Central Contact

Matthew Buman, PhD

✉ mbuman@asu.edu

📞 602-496-8617

Principal Investigator

Matthew Buman, PhD

PRINCIPAL INVESTIGATOR

Arizona State University College of Health Solutions

Frequently Asked Questions

Who can join the NCT05485675 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sedentary Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05485675 currently recruiting?

Yes, NCT05485675 is actively recruiting participants. Contact the research team at mbuman@asu.edu for enrollment information.

Where is the NCT05485675 trial being conducted?

This trial is being conducted at Phoenix, United States.

Who is sponsoring the NCT05485675 clinical trial?

NCT05485675 is sponsored by Arizona State University. The principal investigator is Matthew Buman, PhD at Arizona State University College of Health Solutions. The trial plans to enroll 4,800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology